逐梦“名方变好药” 中药“智造”涌春潮

Core Viewpoint - The integration of traditional Chinese medicine (TCM) with modern technology is driving innovation in the Chinese medicine manufacturing industry, exemplified by Kangyuan Pharmaceutical's efforts to modernize ancient formulas for contemporary clinical use [1][2][10]. Group 1: Innovation in Manufacturing - Kangyuan Pharmaceutical has established a fully automated production line that utilizes smart robotics and AI algorithms to optimize production processes, enhancing efficiency and quality control [2][6]. - The company has developed a unique quality control system centered around effective components, significantly increasing the number of monitored quality indicators from 3-5 to 30-50 [3][5]. - Kangyuan has created the first AI-driven pharmaceutical process knowledge system, marking a breakthrough in intelligent manufacturing for traditional Chinese medicine [6][10]. Group 2: Research and Development - The company focuses on transforming classic formulas from ancient texts like "Shang Han Lun" and "Jin Gui Yao Lue" using modern omics technologies, resulting in a knowledge graph with 120,000 ancient formula data entries [3][4]. - Kangyuan has achieved notable success in new drug approvals, with 59 traditional Chinese medicine new drugs and 6 approved in the last five years, leading the industry in innovation [3][4]. - The company emphasizes a clinical value-oriented approach, ensuring that new drug development is closely tied to clinical efficacy and safety [8][9]. Group 3: Talent and Collaboration - Kangyuan has built a strong research team of over 700 high-level talents, including several recognized experts and scholars, to drive innovation in traditional Chinese medicine [9]. - The company has established a collaborative ecosystem involving national and provincial research platforms to enhance innovation and technological upgrades across the industry [7][10]. - Kangyuan's commitment to talent development is evident through various training programs and recognition received for its research initiatives [9].